CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 45 filers reported holding CONMED CORP in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,474,869 | -24.0% | 13,211,000 | 0.0% | 0.17% | -28.1% |
| Q2 2023 | $20,370,445 | +42.9% | 13,211,000 | +14.9% | 0.24% | +43.2% |
| Q1 2023 | $14,252,165 | +37.1% | 11,497,000 | +27.8% | 0.17% | +56.5% |
| Q4 2022 | $10,397,505 | +5.4% | 8,997,000 | 0.0% | 0.11% | +1.9% |
| Q3 2022 | $9,862,000 | +75.8% | 8,997,000 | +94.4% | 0.11% | +89.3% |
| Q2 2022 | $5,610,000 | +247.4% | 4,628,000 | +362.8% | 0.06% | +366.7% |
| Q2 2021 | $1,615,000 | -91.6% | 1,000,000 | -92.7% | 0.01% | -91.5% |
| Q4 2020 | $19,254,000 | -43.0% | 13,722,000 | -54.3% | 0.14% | -53.0% |
| Q3 2020 | $33,801,000 | +56.5% | 30,049,000 | +46.2% | 0.30% | +38.2% |
| Q2 2020 | $21,594,000 | – | 20,559,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 50,065,000 | $86,599,000 | 6.97% |
| III Capital Management | 12,488,000 | $21,464,000 | 1.87% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,035,000 | $6,946,000 | 1.55% |
| SHENKMAN CAPITAL MANAGEMENT INC | 6,082,000 | $10,261,000 | 1.29% |
| SSI INVESTMENT MANAGEMENT LLC | 6,448,000 | $11,078,000 | 0.60% |
| MACKAY SHIELDS LLC | 38,008,000 | $65,472,000 | 0.58% |
| Eisler Capital (UK) Ltd. | 9,500,000 | $16,280,000 | 0.27% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 53,974,000 | $93,024,000 | 0.26% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 2,607,000 | $4,493,000 | 0.25% |
| Polar Asset Management Partners Inc. | 10,000,000 | $17,137,000 | 0.18% |